Immatics (IMTX) Gains from Investment Securities (2020 - 2025)

Immatics (IMTX) reported Gains from Investment Securities of -$150550.6 for Q2 2025, down 121.57% on a YoY basis from $697823.1 in Q2 2024, and up 91.04% sequentially from -$1.7 million in Q1 2025.

Immatics (IMTX) Gains from Investment Securities (2020 - 2025) Analysis & Trends

Immatics (IMTX) has 6 years of Gains from Investment Securities data on file, last reported at -$150550.6 in Q2 2025.

  • For the quarter ending Q2 2025, Gains from Investment Securities fell 121.57% year-over-year to -$150550.6; the trailing twelve-month figure through Dec 2025 stood at -$1.8 million (up 90.15% YoY), and the FY2025 full-year result was -$2.0 million, up 89.54% from the prior year.
  • Gains from Investment Securities advanced to -$150550.6 in Q2 2025, from -$1.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $14.3 million in Q2 2023 to a low of -$18.5 million in Q1 2022.
  • A 5-year average of -$1.1 million and a median of $273636.3 in 2024 frame the typical range for Gains from Investment Securities.
  • Across the five-year window, Gains from Investment Securities plunged 1365.71% in 2022 and soared 380.2% in 2023, its largest moves.
  • Tracing IMTX's Gains from Investment Securities over 5 years: stood at $1.8 million in 2021, then plunged by 270.8% to -$3.1 million in 2022, then tumbled by 144.09% to -$7.6 million in 2023, then plunged by 82.33% to -$13.9 million in 2024, then surged by 98.92% to -$150550.6 in 2025.
  • Business Quant data shows IMTX's Gains from Investment Securities at -$150550.6 in Q2 2025, -$1.7 million in Q1 2025, and -$13.9 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,132.22 Bn 67,131.94 Bn -
2 Nanobiotix 1,910.87 Bn 1,910.81 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.60 Bn 466.80 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.71 Bn 114.46 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.83 Bn 61.07 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.33 Bn 34.32 Bn 959.66 Mn
10 Immatics 1.08 Bn 533.40 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -150,550.64
Jun 30, 2025 -150,550.64
Mar 31, 2025 -1.68 Mn
Mar 31, 2025 -1.68 Mn
Dec 31, 2024 -13.93 Mn
Dec 31, 2024 -13.93 Mn
Sep 30, 2024 -4.21 Mn
Sep 30, 2024 -4.21 Mn
Jun 30, 2024 697,823.15
Jun 30, 2024 697,823.15
Mar 31, 2024 -1.13 Mn
Mar 31, 2024 -1.13 Mn
Dec 31, 2023 -7.64 Mn
Dec 31, 2023 -7.64 Mn
Sep 30, 2023 1.52 Mn
Sep 30, 2023 1.52 Mn
Jun 30, 2023 14.27 Mn
Jun 30, 2023 14.27 Mn
Mar 31, 2023 -7.94 Mn
Mar 31, 2023 -7.94 Mn